drugset / Trial / NCT06867497
A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this clinical study is to compare and evaluate the pharmacokinetic characteristics and the safety between administration of BR2021 and BR2021-1 in patients with metastatic adenocarcinoma of the pancreas
Timeline
- Start
- 2025-02-24
- Primary completion
- 2025-10-28
- Completion
- 2025-10-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BR2021 | Unknown | — | Intravenous |
| Comparator | BR2021-1 | Unknown | — | Intravenous |